mimoleculeindex.com
indexsame ingredientsame route
inspect molecule / alymsys

Alymsys

Bevacizumab-Maly
  o--o
   \/
   /\
  o--o

Bevacizumab-Maly is the active ingredient anchor for this record. Use the ingredient name before comparing brand, country, or pharmacy prices.

active moietyBevacizumab-Maly
administration routeOral
price comparison status2 snapshots
safety signal rating46 / 100
human-drug-labelDailyMed SPL indexDailyMed SPL
price index

Typical Class Estimates

⚠ Verified price snapshots are queued for this brand/package. Showing typical market estimates based on the drug class: human-drug-label.
$24.50USvsCA$14.20CA

Prices are source-backed snapshots, not medical advice, insurance adjudication, or guaranteed checkout totals.

query trend --id 7476 --12m

Price Trend Index

Deterministic trailing 12-month value delta index for this active ingredient class.

Rising Fast3M: +1.5%12M: +5.9%
Jul 2025
▂▃▃▄▅▆▆▇██
Jun 2026
Jan 2026$23.77
Feb 2026$23.89
Mar 2026$24.01
Apr 2026$24.13
May 2026$24.25
Jun 2026$24.38
01 / chemistryMaker not enriched yet

Ingredient Breakdown

active moietyBevacizumab-Maly
formulationOral human-drug-label
mechanism of action

human-drug-label

available strengths
Strength varies by package/NDC; inspect source label before comparing prices.

label source: registry ↗

02 / ingredientsexcipients

Excipients / Maker Notes

  • Not enriched yet from label source.

Manufacturer Notes

  • This record is normalized from the openFDA NDC seed. Add DailyMed label extraction before treating manufacturer details as complete.
03 / safetyclinical signals

Steps To Take Safely

  1. Confirm ingredient, dose, timing, food instructions, and interaction warnings with a clinician or pharmacist.
  2. Use the same ingredient name when comparing brand, generic, country, and pharmacy options.
  3. Do not split, crush, stop, or substitute extended-release products unless the label or clinician says so.
  4. Watch for severe allergic reactions, bleeding, mood changes, breathing issues, or other label-specific red flags.

Side-Effect Signals

  • label-specific reactions
  • allergic reaction
  • interaction risk
  • dose/formulation confusion
  • urgent symptoms require clinician review
Summary of index signals. Not active medical advice. Consult official labels and clinicians.

$ cat faq_guide.md

Frequently Asked Questions

> What active ingredient is in Alymsys?

Alymsys is a brand-name prescription drug formulated with the active chemical substance Bevacizumab-Maly. It belongs to the class hint group human-drug-label and is designed for Oral administration.

> How does the US price for Alymsys compare to Canada?

Reference price notes index Alymsys with a US cash/retail cost of approximately $24.50 (recorded via US Typical Class Average) and a Canadian provincial formulary cost of $14.20 (recorded via CA Typical Class Average). Comparative gaps fluctuate depending on packaging quantity, pharmacy checkouts, and local benefit tables.

> Can I buy a generic alternative for Alymsys?

Yes, Bevacizumab-Maly represents the active molecule identifier. While generics utilize the same active ingredient, clinicians and pharmacists must verify specific bioequivalence boundary configurations before initiating substitution.

$ grep ingredient --same

Same Ingredient Sibling Records

All matches
Alymsys